Discovery of novel 2,4-diarylaminopyrimidine hydrazone derivatives as potent anti-thyroid cancer agents capable of inhibiting FAK

Guardado en:

Detalles Bibliográficos
Publicado en:	Journal of Enzyme Inhibition and Medicinal Chemistry vol. 39, no. 1 (Dec 2024)
Autor principal:	Li, Hongting
Otros Autores:	Mei-Qi Jia, Zhao-Long, Qin, Lu, Changliang, Chu, Weili, Zhang, Ze, Niu, Jinbo, Song, Jian, Sai-Yang, Zhang, Fu, Lijun
Publicado:	Taylor & Francis Ltd.
Materias:	Cytotoxicity Cell migration Thyroid cancer Phosphorylation Pharmacokinetics Focal adhesion kinase Cell proliferation Thyroidectomy Hydrogen bonds Pharmaceutical sciences Cancer therapies Clinical trials Chemistry Design Enzymes Kinases
Acceso en línea:	Citation/Abstract Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!